Last edition
News about "INTENT Biologics "
INTENT Biologics Secures FDA Breakthrough Therapy Tag for Diabetic Foot Ulcer Treatment Candidate
INTENT Biologics' PEP Biologic receives FDA Breakthrough Therapy designation for diabetic foot ulcers, accelerating development of its first-in-class exosome-based regenerative treatment aimed at improving healing outcomes in chronic wounds.
INTENT Biologics | 03/07/2026 | By News Bureau | 188
RION Forms INTENT Biologics to Develop Clinical Exosome-Based Therapies
With the launch of INTENT Biologics, RION targets global impact in inflammation care; Suneet Varma named CEO to lead the charge.
INTENT Biologics | 11/09/2025 | By Dineshwori | 558
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy